Mesenchymal stem cells (MSCs) are promising candidates for regenerative therapies, particularly for the treatment of degenerative diseases. Various strategies have been developed to enhance the therapeutic potential of MSCs, including culture modification or preconditioning. Hypoxia and lipopolysaccharide (LPS) exposure individually have been reported to affect cell viability, proliferatio…